peptide

Canaccord and William Blair also increased their price targets on  Quidel's shares, following its acquisition of certain Alere assets and assays.

A 7 kiloDalton polypeptide known as "non-annotated P-body dissociating polypeptide," or NoBody, appears to contribute to messenger RNA decapping.

The researchers reported correcting beta thalassemia in a mouse model via a gene editing method delivered by an intravenous injection.

The partners will collaborate on point-of-care tests for validating the identity and activity of biologics and biosimilars.

Arrowhead Research and Shire this week announced that they have struck an alliance to develop and commercialize drugs combining Arrowhead's targeted delivery peptides and Shire's therapeutic payloads.

Arrowhead Research said this week that it has signed a deal under which an undisclosed Merck subsidiary will evaluate a novel therapeutic monoclonal antibody candidate developed through its human-derived peptide targeting and discovery program.

Arrowhead Research said this week that it has expanded its portfolio of drug-delivery technologies through the acquisition of privately held Alvos Therapeutics for roughly $2.1 million in stock.

Marina Biotech said last week that it has received a notice of allowance from the US Patent and Trademark Office for a patent application that covers a library of novel peptides.

RXi also broke out its financial results for 2010 in the filing, reporting a drop in its net loss amid lower research and development spending. The company said, however, that it anticipates its expenses to increase going forward on NeuVax-related expenses.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.